Saturday, Dec 10th

Last update:10:30:34 AM GMT

Headlines:
Load a sample iFrame " href="/gujarati/others/vedio-gujarati">Video-Gujarati

Matrix is Main Supplier to Clinton AIDS Plan

Matrix
Matrix Laboratories Limited announced that it has been selected by the Clinton HIV/AIDS Initiative (CHAI) under its UNITAID–funded projects as the primary supplier of five antiretroviral (ARVs) drugs used in the secondline HIV/AIDS treatment regiments.

It also has been selcted as the primary supplier of seven ARVs used for peadiatric treatment.

Matrix chairman Robert J Coury said that Mylan and Matrix were committed to increasing access for patients in developing countries through its innovations and expertise.

According to the UNAIDS, an estimated 33 million people in the world are infected with HIV and more than 90 per cent of these patients in developing worlk and less than 4 million patients receive treatment.

He said that 30 per cent of the patients in developing countries depend on Matrix ARV products, according to a release.

Matrix’s second–line products selected for the 2009 UNITAID–CHAI projects include heat–stable Lopinavir/Ritonarvir, the release added.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.

Source: Business Standard

સુચના

 
આ આપની સાઈટ છે, સુચના અથવા પ્રતિક્રીયા આવકાર્ય છે. જણાવશો, તો અમો તેના આધારે ઉત્તમ કરવાના પ્રયત્‍નો કરશું.

સુચના જણાવો

વાર્તાપત્ર

 
Newsletters

Link to Aarogya

 

પ્રકાશન

 
Know Your Rights!

અમારીસાથી આઓ